{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"lafora-disease","columns":[{"gene":"","key":"population-0b63d90489b80e1f3915","label":"Lafora disease","mondoId":"MONDO:0009697","onsetQualifier":null,"originColumnKey":"MONDO:0009697/ORPHA:501","originalViews":[{"key":"MONDO:0009697/ORPHA:501","label":"Lafora disease","scopeLabel":"ORPHA:501","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["021e2e03af7887d133ed517c322091258ac1eee9aa24df8791755688d21bfba3","0db93ff5267f866fdde2a70aacee6164939ebcdd91604e66911da90e4a151e02","169f711f59f2f6d9dc0335b4efd604644337ab7bcfa7e3dd7bae5b5e2d54a402","16eae8483563256d037a0e2635cfb536dd5468031e1ca43ac134ee3ae817a96e","22c8154c106e2decd04a45fe5dfc3cce5d289dcc70b11d4732959b170a3aaf99","2c5b1412801a2b9ad3b3765472489f0c63a745e2d8072a252f52b7c09e61909f","2dd3425968438dd2d18d73d95f1269c07b9498470283d04c8d0151720ff9de01","336ba44825e1020e63d30471e40c23c3022de46a5ca9ed15462023acdb42396c","3611db611ca9a7990661aa1b98e8f2622a9cb200d8d09a24134cbb83ae76b045","386e5cc5adef8fd1996ff44014b685ef012af86556d30b85ada67772868c0f9a","405efca2ad1bcc81a49cf5d124fe12f0b7967f572e249777f620d43cbcf9ed95","411c214458b30d5edd30aef2a20d7dfae669bdf50724ccb365a954971ba4475d","4468340eea7e6b31ed22f145d0d01ff8b9f4f46a157556dfcd5945ec1877a953","47a1e04da177dbd8cebe69380357146e048c240b392cac97ea40e4632911cdca","58e59e8f29401326679099f5d52e1c2bd1450241d761ead3f27d6eb9585a6ef7","62e1a02c12d06c5ab86ff8f9b1374d7d77f1abe03b4fd1bb8f1d88d286763e78","6b1234fbe106e2e4c0c6eaabd90e275c99caee58f0241e6673f14af4f3489985","6e2ebb8507ccef884ee81ac90b0e6cdeefce9ec4a4e32291447e16d6899276aa","6e57b7dd013d90eb0d64d01ce50c037840d4739d63fa2733a3c0282851736015","76ae2268cf515a1097af90380ba7e0a55cb141c9cee6356ad75039b3e951852e","779b70e8aff3c423312ac8a75f606cd428e26be6ff40b18fd53527993c37247f","8311db962ec7c4e83c742c7dd9505795d93873f3fa0b729117ea3a740a70e91c","87faeac959723af84c15467f69b7a45efe5f2be7b107f759cc3e61beea9c54b9","88ebdf2b6e001a2a2be37b09e3de5c154acfe8bce5dac05dce27b8cfcf482897","9be00b471c9b66fb97f76b2db52b9332777efef576d8cc47e9a642e2f28199cb","aba34e52ba1d7500039e61d09848d76dd7d45cdb992f3ff8d48bef91ed9db2db","ae574bbffc853840720b59c1c66abcd4957d41472ccee7454b7332abcde50169","bcdee9c43e5ac4f58042db03f58208a70546a268347311978ed4ae2a52f0645e","c37a082bde50fc70734c700f738d8766871079959b38f7f2615f6a4bf7af181c","c39846978f4d82f8ca2fb905276d11fa3dda32f21159c8c96a701e77e899e842","e3b3e83c23c126e994454e711ad654e5811c51543adcc43cb191fee08362f623","e59579ed5aa243e0efd6ddf3b08c32a15c0fa20681a6a9ee06264452d5eb79d7","ee1afda471ab748679fd10c6ee21665ce57a5c7b763034120cfbe2185c1a9ad8","f155b23477ec68b9819659ce2dc3155891ec46a1a8a835da71667e851478dad3","f4f7f94d478e4c74304f275770e89085e9eae8a36b352e4beb895d2c24150e4a"],"recordQualifiers":{},"scopeLabel":"ORPHA:501","sourceIds":["ORPHA:501"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-0b63d90489b80e1f3915"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0001251","HP:0010819","HP:0007270","HP:0002069","HP:0007334","HP:0012444","HP:0001289"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":35,"sourceGroups":{"orphanet":35}},"features":[{"hpoId":"HP:0001251","label":"Ataxia","primary":true},{"hpoId":"HP:0010819","label":"Atonic seizure","primary":true},{"hpoId":"HP:0007270","label":"Atypical absence seizure","primary":true},{"hpoId":"HP:0002069","label":"Bilateral tonic-clonic seizure","primary":true},{"hpoId":"HP:0007334","label":"Bilateral tonic-clonic seizure with focal onset","primary":true},{"hpoId":"HP:0012444","label":"Brain atrophy","primary":true},{"hpoId":"HP:0001289","label":"Confusion","primary":true},{"hpoId":"HP:0000726","label":"Dementia","primary":false},{"hpoId":"HP:0000716","label":"Depression","primary":false},{"hpoId":"HP:0001260","label":"Dysarthria","primary":false},{"hpoId":"HP:0000712","label":"Emotional lability","primary":false},{"hpoId":"HP:0025357","label":"Erratic myoclonus","primary":false},{"hpoId":"HP:0002384","label":"Focal impaired awareness seizure","primary":false},{"hpoId":"HP:0011165","label":"Focal sensory seizure with visual features","primary":false},{"hpoId":"HP:0007359","label":"Focal-onset seizure","primary":false},{"hpoId":"HP:0001288","label":"Gait disturbance","primary":false},{"hpoId":"HP:0002123","label":"Generalized myoclonic seizure","primary":false},{"hpoId":"HP:0002121","label":"Generalized non-motor (absence) seizure","primary":false},{"hpoId":"HP:0001312","label":"Giant somatosensory evoked potentials","primary":false},{"hpoId":"HP:0002315","label":"Headache","primary":false},{"hpoId":"HP:0001399","label":"Hepatic failure","primary":false},{"hpoId":"HP:0002521","label":"Hypsarrhythmia","primary":false},{"hpoId":"HP:0002540","label":"Inability to walk","primary":false},{"hpoId":"HP:0100318","label":"Lafora bodies","primary":false},{"hpoId":"HP:0001268","label":"Mental deterioration","primary":false},{"hpoId":"HP:0001336","label":"Myoclonus","primary":false},{"hpoId":"HP:0040288","label":"Nasogastric tube feeding","primary":false},{"hpoId":"HP:0002100","label":"Recurrent aspiration pneumonia","primary":false},{"hpoId":"HP:0001250","label":"Seizure","primary":false},{"hpoId":"HP:0007537","label":"Severe photosensitivity","primary":false},{"hpoId":"HP:0002360","label":"Sleep disturbance","primary":false},{"hpoId":"HP:0001257","label":"Spasticity","primary":false},{"hpoId":"HP:0002133","label":"Status epilepticus","primary":false},{"hpoId":"HP:0031358","label":"Vegetative state","primary":false},{"hpoId":"HP:0002367","label":"Visual hallucination","primary":false}],"ledeHtml":"Lafora progressive myoclonus epilepsy is a brain disorder characterized by recurrent seizures (epilepsy) and a decline in intellectual function. The signs and symptoms of the disorder usually appear in late childhood or adolescence and worsen with time.","mondoId":"MONDO:0009697","node":{"canonicalSlug":"lafora-disease","comparisons":[{"documentSha256":"383d88d501ff400a5af9e4da96a48703ad7367ebdd8b8ac20a3e062255755372","key":"prepared-lafora-disease","kind":"prepared","label":"Lafora disease","memberIds":["MONDO:0009697","MONDO:0800306","MONDO:0958199"],"mondoId":"MONDO:0009697","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-383d88d501ff400a5af9.383d88d501ff400a5af9e4da96a48703ad7367ebdd8b8ac20a3e062255755372.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":["Lafora progressive myoclonus epilepsy can be caused by mutations in either the EPM2A gene or the NHLRC1 gene. These genes provide instructions for making proteins called laforin and malin, respectively. Laforin and malin play a critical role in the survival of nerve cells (neurons) in the brain.","Studies suggest that laforin and malin work together and may have several functions. One of these is to help regulate the production of a complex sugar called glycogen, which is a major source of stored energy in the body. The body stores this sugar in the liver and muscles, breaking it down when it is needed for fuel. Laforin and malin may prevent a potentially damaging buildup of glycogen in tissues that do not normally store this molecule, such as those of the nervous system.","Researchers have discovered that people with Lafora progressive myoclonus epilepsy have distinctive clumps called Lafora bodies within their cells. Lafora bodies are made up of an abnormal form of glycogen that cannot be broken down and used for fuel. Instead, it builds up to form clumps that can damage cells. Neurons appear to be particularly vulnerable to this type of damage. Although Lafora bodies are found in many of the body's tissues, the signs and symptoms of Lafora progressive myoclonus epilepsy are limited to the nervous system.","Mutations in the EPM2A gene prevent cells from making functional laforin, while NHLRC1 gene mutations prevent the production of functional malin. It is unclear how a loss of either of these proteins leads to the formation of Lafora bodies. However, a loss of laforin or malin ultimately results in the death of neurons, which interferes with the brain's normal functions. The condition tends to progress more slowly in some people with NHLRC1 gene mutations than in those with EPM2A gene mutations.","Mutations in the EPM2A and NHLRC1 genes account for 80 percent to 90 percent of all cases of Lafora progressive myoclonus epilepsy. In the remaining cases, the cause of the condition is unknown. Researchers are searching for other genetic changes that may underlie this disease."],"causesUrl":"https://medlineplus.gov/genetics/condition/lafora-progressive-myoclonus-epilepsy/#causes","contentForm":"summary","matchMethod":"reviewed-binding","name":"Lafora progressive myoclonus epilepsy","paragraphs":["Lafora progressive myoclonus epilepsy is a brain disorder characterized by recurrent seizures (epilepsy) and a decline in intellectual function. The signs and symptoms of the disorder usually appear in late childhood or adolescence and worsen with time.","Myoclonus is a term used to describe episodes of sudden, involuntary muscle jerking or twitching that can affect part of the body or the entire body. Myoclonus can occur when an affected person is at rest, and it is made worse by motion, excitement, or flashing light (photic stimulation). In the later stages of Lafora progressive myoclonus epilepsy, myoclonus often occurs continuously and affects the entire body.","Several types of seizures commonly occur in people with Lafora progressive myoclonus epilepsy. Generalized tonic-clonic seizures (also known as grand mal seizures) affect the entire body, causing muscle rigidity, convulsions, and loss of consciousness. Affected individuals may also experience occipital seizures, which can cause temporary blindness and visual hallucinations. Over time, the seizures worsen and become more difficult to treat. A life-threatening seizure condition called status epilepticus may also develop. Status epilepticus is a continuous state of seizure activity lasting longer than several minutes.","About the same time seizures begin, intellectual function starts to decline. Behavioral changes, depression, confusion, and speech difficulties (dysarthria) are among the early signs and symptoms of this disorder. As the condition worsens, a continued loss of intellectual function (dementia) impairs memory, judgment, and thought. Affected people lose the ability to perform the activities of daily living by their mid-twenties, and they ultimately require comprehensive care. People with Lafora progressive myoclonus epilepsy generally survive up to 10 years after symptoms first appear."],"reviewed":"2009-07","scope":"exact","scopeNote":"Lafora disease caused by EPM2A or NHLRC1 changes, not the broader progressive myoclonus epilepsy grouping. The source Causes section explicitly covers both genes.","source":"MedlinePlus","sourceRelease":"2026-10-01","upstream":"MedlinePlus Genetics","url":"https://medlineplus.gov/genetics/condition/lafora-progressive-myoclonus-epilepsy"},"ownColumnKeys":["population-0b63d90489b80e1f3915"],"publication":"published","relationships":[{"kind":"parent","label":"disorder of glycogen metabolism","mondoId":"MONDO:0002412","slug":"disorder-of-glycogen-metabolism"},{"kind":"parent","label":"movement disorder","mondoId":"MONDO:0005395","slug":null},{"kind":"parent","label":"progressive myoclonus epilepsy","mondoId":"MONDO:0020074","slug":"progressive-myoclonus-epilepsy"},{"kind":"child","label":"myoclonic epilepsy of Lafora 2","mondoId":"MONDO:0800306","slug":"myoclonic-epilepsy-of-lafora-2"},{"kind":"child","label":"myoclonic epilepsy of Lafora 1","mondoId":"MONDO:0958199","slug":"lafora-progressive-myoclonus-epilepsy"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[],"translation":"published","articles":[{"articleId":"rarediseases.info.nih.gov/diseases/8214","pageMondoId":"MONDO:0009697","source":"GARD","name":"Lafora disease","url":"https://rarediseases.info.nih.gov/diseases/8214","relationToPage":"same-condition","coveredMondoIds":["MONDO:0009697"],"status":"validated-exact-source","presentation":"additional-reference","evidence":["existing-offline-scope-validator","automatic-identity-and-attribution"],"reviewed":null,"sourceRelease":"2026-10-21T22:46:34Z","upstream":"GARD:0008214","rawAttribution":"MONDO:0009697","independentCorroborationEstablished":false}]},"records":[{"frequencyKind":"range","key":"021e2e03af7887d133ed517c322091258ac1eee9aa24df8791755688d21bfba3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002367","is_excluded":false,"label":"Visual hallucination","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"0db93ff5267f866fdde2a70aacee6164939ebcdd91604e66911da90e4a151e02","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0031358","is_excluded":false,"label":"Vegetative state","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"169f711f59f2f6d9dc0335b4efd604644337ab7bcfa7e3dd7bae5b5e2d54a402","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001251","is_excluded":false,"label":"Ataxia","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"16eae8483563256d037a0e2635cfb536dd5468031e1ca43ac134ee3ae817a96e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0011165","is_excluded":false,"label":"Focal sensory seizure with visual features","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"22c8154c106e2decd04a45fe5dfc3cce5d289dcc70b11d4732959b170a3aaf99","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002133","is_excluded":false,"label":"Status epilepticus","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2c5b1412801a2b9ad3b3765472489f0c63a745e2d8072a252f52b7c09e61909f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002315","is_excluded":false,"label":"Headache","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"2dd3425968438dd2d18d73d95f1269c07b9498470283d04c8d0151720ff9de01","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000716","is_excluded":false,"label":"Depression","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"336ba44825e1020e63d30471e40c23c3022de46a5ca9ed15462023acdb42396c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002360","is_excluded":false,"label":"Sleep disturbance","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"3611db611ca9a7990661aa1b98e8f2622a9cb200d8d09a24134cbb83ae76b045","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002121","is_excluded":false,"label":"Generalized non-motor (absence) seizure","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"386e5cc5adef8fd1996ff44014b685ef012af86556d30b85ada67772868c0f9a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001257","is_excluded":false,"label":"Spasticity","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"405efca2ad1bcc81a49cf5d124fe12f0b7967f572e249777f620d43cbcf9ed95","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002384","is_excluded":false,"label":"Focal impaired awareness seizure","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"411c214458b30d5edd30aef2a20d7dfae669bdf50724ccb365a954971ba4475d","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000712","is_excluded":false,"label":"Emotional lability","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"4468340eea7e6b31ed22f145d0d01ff8b9f4f46a157556dfcd5945ec1877a953","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002521","is_excluded":false,"label":"Hypsarrhythmia","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"47a1e04da177dbd8cebe69380357146e048c240b392cac97ea40e4632911cdca","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001336","is_excluded":false,"label":"Myoclonus","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"58e59e8f29401326679099f5d52e1c2bd1450241d761ead3f27d6eb9585a6ef7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007270","is_excluded":false,"label":"Atypical absence seizure","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"62e1a02c12d06c5ab86ff8f9b1374d7d77f1abe03b4fd1bb8f1d88d286763e78","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0002069","is_excluded":false,"label":"Bilateral tonic-clonic seizure","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6b1234fbe106e2e4c0c6eaabd90e275c99caee58f0241e6673f14af4f3489985","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0001399","is_excluded":false,"label":"Hepatic failure","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6e2ebb8507ccef884ee81ac90b0e6cdeefce9ec4a4e32291447e16d6899276aa","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001288","is_excluded":false,"label":"Gait disturbance","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"6e57b7dd013d90eb0d64d01ce50c037840d4739d63fa2733a3c0282851736015","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007359","is_excluded":false,"label":"Focal-onset seizure","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"76ae2268cf515a1097af90380ba7e0a55cb141c9cee6356ad75039b3e951852e","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007537","is_excluded":false,"label":"Severe photosensitivity","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"779b70e8aff3c423312ac8a75f606cd428e26be6ff40b18fd53527993c37247f","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0010819","is_excluded":false,"label":"Atonic seizure","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"8311db962ec7c4e83c742c7dd9505795d93873f3fa0b729117ea3a740a70e91c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001289","is_excluded":false,"label":"Confusion","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"87faeac959723af84c15467f69b7a45efe5f2be7b107f759cc3e61beea9c54b9","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002123","is_excluded":false,"label":"Generalized myoclonic seizure","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"88ebdf2b6e001a2a2be37b09e3de5c154acfe8bce5dac05dce27b8cfcf482897","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001250","is_excluded":false,"label":"Seizure","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"9be00b471c9b66fb97f76b2db52b9332777efef576d8cc47e9a642e2f28199cb","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040280","hpo_id":"HP:0100318","is_excluded":false,"label":"Lafora bodies","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"aba34e52ba1d7500039e61d09848d76dd7d45cdb992f3ff8d48bef91ed9db2db","raw":{"aspect":"P","body_system":"immune","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002100","is_excluded":false,"label":"Recurrent aspiration pneumonia","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ae574bbffc853840720b59c1c66abcd4957d41472ccee7454b7332abcde50169","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001312","is_excluded":false,"label":"Giant somatosensory evoked potentials","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"bcdee9c43e5ac4f58042db03f58208a70546a268347311978ed4ae2a52f0645e","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001268","is_excluded":false,"label":"Mental deterioration","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c37a082bde50fc70734c700f738d8766871079959b38f7f2615f6a4bf7af181c","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0002540","is_excluded":false,"label":"Inability to walk","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c39846978f4d82f8ca2fb905276d11fa3dda32f21159c8c96a701e77e899e842","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0001260","is_excluded":false,"label":"Dysarthria","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e3b3e83c23c126e994454e711ad654e5811c51543adcc43cb191fee08362f623","raw":{"aspect":"P","body_system":"digestive","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0040288","is_excluded":false,"label":"Nasogastric tube feeding","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"e59579ed5aa243e0efd6ddf3b08c32a15c0fa20681a6a9ee06264452d5eb79d7","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0025357","is_excluded":false,"label":"Erratic myoclonus","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"ee1afda471ab748679fd10c6ee21665ce57a5c7b763034120cfbe2185c1a9ad8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0012444","is_excluded":false,"label":"Brain atrophy","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f155b23477ec68b9819659ce2dc3155891ec46a1a8a835da71667e851478dad3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040282","hpo_id":"HP:0000726","is_excluded":false,"label":"Dementia","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"f4f7f94d478e4c74304f275770e89085e9eae8a36b352e4beb895d2c24150e4a","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"ORPHA:501","disease_name":"Lafora disease","evidence":"TAS","frequency_raw":"HP:0040283","hpo_id":"HP:0007334","is_excluded":false,"label":"Bilateral tonic-clonic seizure with focal onset","onset_id":null,"reference":"ORPHA:501","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/lafora-progressive-myoclonus-epilepsy\" rel=\"noreferrer\">MedlinePlus</a> · Lafora disease caused by EPM2A or NHLRC1 changes, not the broader progressive myoclonus epilepsy grouping. The source Causes section explicitly covers both genes.</p><p class=\"section-source\">Source: <a href=\"https://rarediseases.info.nih.gov/diseases/8214\" rel=\"noreferrer\">GARD</a></p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0009697\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>summary</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>reviewed-binding</dd><dt>Upstream attribution</dt><dd>MedlinePlus Genetics</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>Lafora progressive myoclonus epilepsy is a brain disorder characterized by recurrent seizures (epilepsy) and a decline in intellectual function. The signs and symptoms of the disorder usually appear in late childhood or adolescence and worsen with time.</p><p>Myoclonus is a term used to describe episodes of sudden, involuntary muscle jerking or twitching that can affect part of the body or the entire body. Myoclonus can occur when an affected person is at rest, and it is made worse by motion, excitement, or flashing light (photic stimulation). In the later stages of Lafora progressive myoclonus epilepsy, myoclonus often occurs continuously and affects the entire body.</p><p>Several types of seizures commonly occur in people with Lafora progressive myoclonus epilepsy. Generalized tonic-clonic seizures (also known as grand mal seizures) affect the entire body, causing muscle rigidity, convulsions, and loss of consciousness. Affected individuals may also experience occipital seizures, which can cause temporary blindness and visual hallucinations. Over time, the seizures worsen and become more difficult to treat. A life-threatening seizure condition called status epilepticus may also develop. Status epilepticus is a continuous state of seizure activity lasting longer than several minutes.</p><p>About the same time seizures begin, intellectual function starts to decline. Behavioral changes, depression, confusion, and speech difficulties (dysarthria) are among the early signs and symptoms of this disorder. As the condition worsens, a continued loss of intellectual function (dementia) impairs memory, judgment, and thought. Affected people lose the ability to perform the activities of daily living by their mid-twenties, and they ultimately require comprehensive care. People with Lafora progressive myoclonus epilepsy generally survive up to 10 years after symptoms first appear.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/lafora-progressive-myoclonus-epilepsy\" rel=\"noreferrer\">MedlinePlus</a> · Lafora disease caused by EPM2A or NHLRC1 changes, not the broader progressive myoclonus epilepsy grouping. The source Causes section explicitly covers both genes.</p>","key":"overview","title":"Overview"},{"bodyHtml":"<p>Lafora progressive myoclonus epilepsy can be caused by mutations in either the EPM2A gene or the NHLRC1 gene. These genes provide instructions for making proteins called laforin and malin, respectively. Laforin and malin play a critical role in the survival of nerve cells (neurons) in the brain.</p><p>Studies suggest that laforin and malin work together and may have several functions. One of these is to help regulate the production of a complex sugar called glycogen, which is a major source of stored energy in the body. The body stores this sugar in the liver and muscles, breaking it down when it is needed for fuel. Laforin and malin may prevent a potentially damaging buildup of glycogen in tissues that do not normally store this molecule, such as those of the nervous system.</p><p>Researchers have discovered that people with Lafora progressive myoclonus epilepsy have distinctive clumps called Lafora bodies within their cells. Lafora bodies are made up of an abnormal form of glycogen that cannot be broken down and used for fuel. Instead, it builds up to form clumps that can damage cells. Neurons appear to be particularly vulnerable to this type of damage. Although Lafora bodies are found in many of the body&#x27;s tissues, the signs and symptoms of Lafora progressive myoclonus epilepsy are limited to the nervous system.</p><p>Mutations in the EPM2A gene prevent cells from making functional laforin, while NHLRC1 gene mutations prevent the production of functional malin. It is unclear how a loss of either of these proteins leads to the formation of Lafora bodies. However, a loss of laforin or malin ultimately results in the death of neurons, which interferes with the brain&#x27;s normal functions. The condition tends to progress more slowly in some people with NHLRC1 gene mutations than in those with EPM2A gene mutations.</p><p>Mutations in the EPM2A and NHLRC1 genes account for 80 percent to 90 percent of all cases of Lafora progressive myoclonus epilepsy. In the remaining cases, the cause of the condition is unknown. Researchers are searching for other genetic changes that may underlie this disease.</p><p class=\"section-source\">Source: <a href=\"https://medlineplus.gov/genetics/condition/lafora-progressive-myoclonus-epilepsy/#causes\" rel=\"noreferrer\">MedlinePlus</a> · Lafora disease caused by EPM2A or NHLRC1 changes, not the broader progressive myoclonus epilepsy grouping. The source Causes section explicitly covers both genes.</p>","key":"causes","title":"Causes"}],"sharedSources":[],"slug":"lafora-disease","sourceDocuments":[{"name":"MedlinePlus: Lafora progressive myoclonus epilepsy","reviewed":"2009-07","source_release":"2026-10-01","url":"https://medlineplus.gov/genetics/condition/lafora-progressive-myoclonus-epilepsy"},{"name":"GARD: Lafora disease","reviewed":null,"source_release":"2026-10-21T22:46:34Z","url":"https://rarediseases.info.nih.gov/diseases/8214"},{"name":"MONDO: Lafora disease","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0009697"}],"sourceNote":"","synonyms":["epilepsy progressive myoclonic 2","epilepsy, progressive myoclonic 2A (Lafora)","epilepsy, progressive myoclonic 2B (Lafora)","EPM2","Lafora body disorder","Lafora disease","myoclonic epilepsy of Lafora","PME type 2","progressive myoclonic epilepsy type 2","progressive myoclonus epilepsy type 2"],"takeawayHtml":"","title":"Lafora disease"},"schemaVersion":1}
